Cao Zhaolong, chief physician of the Department of Respiratory and Intensive Medicine at Peking University People’s Hospital and a member of the medical team’s expert team, said that over the years, the hospital has made great progress in its ability to respond to sudden infectious diseases.
He said that after experiencing SARS in 2003 and A1 in 2009, he has some experience in respiratory infectious diseases at the national level and at the hospital level. “Now the establishment of an infectious disease prevention and control system in the country, including the reporting of unexplained pneumonia, the diagnosis and treatment process for severely ill patients with respiratory infectious diseases, etc., has played a very good role in our response to avian influenza and influenza A.
Cao Zhaolong said that the country’s overall treatment capacity has been greatly improved. We have many experts and the MDT (Clinical Multidisciplinary Comprehensive Treatment) team to provide the best treatment for patients. For example, the excessive use of hormones in 2003, including long-term large-dose use of antiviral drugs, caused some adverse reactions. “This time we are very careful about the use of antiviral drugs, hormones and various drugs. We check the details and play a very good role in the rehabilitation of patients.”
“We have had multiple treatments for respiratory tract infectious diseases. Now we have a professional treatment team that can provide patients with corresponding treatments including high-flow oxygen inhalation, non-invasive ventilation, and ECMO.” He said.
He also said that the equipment for respiratory therapy has also been greatly improved over the years. For example, in 2003, there was no ECMO and no nasal high-flow oxygen inhalation devices. Now some of these devices are brought from the hospital to the front line, and some are coordinated through local hospitals. “Including the superiority of the joint defense and joint control mechanism, the nationwide anti-epidemic also provides a good guarantee for combating the new coronary pneumonia epidemic.”